ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VFY Vitrafy Life Sciences Ltd

1.645
-0.09 (-5.19%)
28 Jan 2025 - Closed
Delayed by 20 minutes

Vitrafy Life Sciences Financial Summary

The current VFY market cap is 5.13M. The company's latest EPS is AUD -3.3456 and P/E is -0.49.

Year End 30 June 2024 202220232024
AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 1.82M2.05M2.06M
Operating Income -4.62M-7.15M-8.62M
Net Income -7.66M-7.81M-10.43M
Year End 30 June 2024 202220232024
AUD (AUD)AUD (AUD)AUD (AUD)
Total Assets 4.37M4.93M9.78M
Total Liabilities 11.64M19.56M34.38M
Total Equity -7.27M-14.63M-24.6M

Cash Flow

Year End 30 June 2024 202220232024
AUD (AUD)AUD (AUD)AUD (AUD)
Operating -5.87M-4.96M-6.79M
Investing -486k-90k-13k
Financing -58k5.81M11.5M
Market Cap 5.13M
Price to Earnings Ratio -0.49
Price to Sales Ratio 2.48
Price to Cash Ratio 0.8
Price to Book Ratio -0.21
Dividend Yield -

Share Statistics

Shares Outstanding 3.12M
Average Volume (1 week) 26.64k
Average Volume (1 Month) 25.72k
52 Week Change -17.75%
52 Week High 2.10
52 Week Low 1.595
Spread (Intraday) 0.07 (4.09%)

Company Info

Company Name Vitrafy Life Sciences Ltd
Address level 1
hobart, tasmania 7000
Website https://vitrafy.com/
Industry coml physical, biologcl resh (8731)